Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-000247
Filing Date
2021-01-06
Accepted
2021-01-06 21:39:17
Documents
1
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 form4-01062021_060108.html 4  
1 form4-01062021_060108.xml 4 3945
  Complete submission text file 0001415889-21-000247.txt   5424
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address
BORKOWSKI EDWARD (Reporting) CIK: 0001197542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 21512841

Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations